Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204222781> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3204222781 endingPage "3201" @default.
- W3204222781 startingPage "3198" @default.
- W3204222781 abstract "Background: Human papilloma virus (HPV) could contribute to warts and prevalence of warts is estimated to be from 7 to 10 percent of population. Immunity system could recognize bacterial, fungal as well as viral antigens. Researchers got benefit of this through development of antigen immunotherapy intralesional management. Purified protein derivative (PPD) is an intralesional immune-treatment for warts that has shown promising results.Objective: To determine whether intralesional PPD is effective and safe in common warts management.Patients and methods: The study involved twenty patients. History taking, general exam, and complete dermatological exam were performed on each patient to determine the type and number of warts, as well as the size and location of each wart in every patient. Without any pre-sensitization, all patients were then given PPD injection of 0.1 ml into the largest wart every two weeks for a maximum of six treatment sessions, or until the wart was completely cleared. The effectiveness of the treatment was determined by the size and number of warts. PPD injections were also evaluated for patient satisfaction and side effects. There was a follow-up evaluation for wart recurrence six months after the end of the treatment.Results: After 1/3 sessions, the mean of wart size reduction was 11.25 ± 14.67 whereas after 2/3 sessions the mean was 29.80 ± 28.72. After all sessions, the wart size reduction ranged from 0 – 100 with a mean of 55.55 ± 42.65. 35% of patients had complete wart clearance, 20% had a moderate response, and 40% had an inadequate response, 5% showed marked response.Conclusion: Common warts can be treated with intralesional immunotherapy using PPD, which is a safe, effective, and tolerable treatment modality." @default.
- W3204222781 created "2021-10-11" @default.
- W3204222781 creator A5036545727 @default.
- W3204222781 creator A5043467056 @default.
- W3204222781 creator A5062233240 @default.
- W3204222781 date "2021-10-01" @default.
- W3204222781 modified "2023-10-17" @default.
- W3204222781 title "Intralesional Injection of Purified Protein Derivative in the Treatment of Viral Warts: A Pilot Study" @default.
- W3204222781 cites W1545183185 @default.
- W3204222781 cites W1936908885 @default.
- W3204222781 cites W1978620450 @default.
- W3204222781 cites W2033829849 @default.
- W3204222781 cites W2064820967 @default.
- W3204222781 cites W2133785508 @default.
- W3204222781 cites W2147028628 @default.
- W3204222781 cites W2438536213 @default.
- W3204222781 cites W2474727776 @default.
- W3204222781 cites W2744980567 @default.
- W3204222781 cites W2966328272 @default.
- W3204222781 cites W3008806662 @default.
- W3204222781 cites W62696810 @default.
- W3204222781 doi "https://doi.org/10.21608/ejhm.2021.195432" @default.
- W3204222781 hasPublicationYear "2021" @default.
- W3204222781 type Work @default.
- W3204222781 sameAs 3204222781 @default.
- W3204222781 citedByCount "0" @default.
- W3204222781 crossrefType "journal-article" @default.
- W3204222781 hasAuthorship W3204222781A5036545727 @default.
- W3204222781 hasAuthorship W3204222781A5043467056 @default.
- W3204222781 hasAuthorship W3204222781A5062233240 @default.
- W3204222781 hasBestOaLocation W32042227811 @default.
- W3204222781 hasConcept C106159729 @default.
- W3204222781 hasConcept C111771559 @default.
- W3204222781 hasConcept C142724271 @default.
- W3204222781 hasConcept C159047783 @default.
- W3204222781 hasConcept C16005928 @default.
- W3204222781 hasConcept C162324750 @default.
- W3204222781 hasConcept C2776247216 @default.
- W3204222781 hasConcept C2781069245 @default.
- W3204222781 hasConcept C2910580931 @default.
- W3204222781 hasConcept C556039675 @default.
- W3204222781 hasConcept C71924100 @default.
- W3204222781 hasConceptScore W3204222781C106159729 @default.
- W3204222781 hasConceptScore W3204222781C111771559 @default.
- W3204222781 hasConceptScore W3204222781C142724271 @default.
- W3204222781 hasConceptScore W3204222781C159047783 @default.
- W3204222781 hasConceptScore W3204222781C16005928 @default.
- W3204222781 hasConceptScore W3204222781C162324750 @default.
- W3204222781 hasConceptScore W3204222781C2776247216 @default.
- W3204222781 hasConceptScore W3204222781C2781069245 @default.
- W3204222781 hasConceptScore W3204222781C2910580931 @default.
- W3204222781 hasConceptScore W3204222781C556039675 @default.
- W3204222781 hasConceptScore W3204222781C71924100 @default.
- W3204222781 hasIssue "1" @default.
- W3204222781 hasLocation W32042227811 @default.
- W3204222781 hasOpenAccess W3204222781 @default.
- W3204222781 hasPrimaryLocation W32042227811 @default.
- W3204222781 hasRelatedWork W2008708209 @default.
- W3204222781 hasRelatedWork W2035909704 @default.
- W3204222781 hasRelatedWork W2364707330 @default.
- W3204222781 hasRelatedWork W2409132194 @default.
- W3204222781 hasRelatedWork W2412709800 @default.
- W3204222781 hasRelatedWork W2418393350 @default.
- W3204222781 hasRelatedWork W2461684097 @default.
- W3204222781 hasRelatedWork W2738981461 @default.
- W3204222781 hasRelatedWork W4234833016 @default.
- W3204222781 hasRelatedWork W4297184974 @default.
- W3204222781 hasVolume "85" @default.
- W3204222781 isParatext "false" @default.
- W3204222781 isRetracted "false" @default.
- W3204222781 magId "3204222781" @default.
- W3204222781 workType "article" @default.